| Income Taxes |
8. Income Taxes
The income tax expense consisted of the following:
| |
|
Year Ended December 31, |
|
| |
|
2022 |
|
|
2021 |
|
| Current income taxes: |
|
|
|
|
|
|
| Federal |
|
$ |
- |
|
|
$ |
- |
|
| State and local |
|
|
- |
|
|
|
- |
|
| Total current tax |
|
|
- |
|
|
|
- |
|
| |
|
|
|
|
|
|
|
|
| Deferred income taxes: |
|
|
|
|
|
|
|
|
| Federal |
|
|
- |
|
|
|
- |
|
| State and local |
|
|
- |
|
|
|
- |
|
| Total deferred tax |
|
|
- |
|
|
|
- |
|
| Income tax expense |
|
$ |
- |
|
|
$ |
- |
|
The effective tax rates on continuing operations for the years ended
December 31, 2021 and 2022 were 0% respectively. The table below reconciles these effective tax rates with the U.S. federal statutory
income tax rate as follows:
| |
|
Year Ended December 31, |
|
| |
|
2022 |
|
|
2021 |
|
| Income (loss) before income taxes |
|
$ |
(28,260,571 |
) |
|
$ |
(15,127,629 |
) |
| Tax at Federal Statutory Rate |
|
|
(5,934,720 |
) |
|
|
(3,176,802 |
) |
| Federal Return to Accrual |
|
|
- |
|
|
|
- |
|
| Non deductible expenses |
|
|
193,421 |
|
|
|
1,754,071 |
|
| Change in valuation allowance |
|
|
5,741,299 |
|
|
|
1,422,731 |
|
| Income tax expense |
|
|
- |
|
|
|
- |
|
| |
|
|
0.00 |
% |
|
|
0.00 |
% |
The Company’s deferred tax position reflects the net tax effects
of the temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used
for income tax reporting. Significant components of the deferred tax assets and liabilities are as follows:
| |
|
Year Ended December 31, |
|
| |
|
2022 |
|
|
2021 |
|
| Deferred tax assets: |
|
|
|
|
|
|
| Fixed Assets |
|
$ |
113,135 |
|
|
$ |
103,863 |
|
| Stock Compensation |
|
|
758,306 |
|
|
|
211,849 |
|
| Warrant Liability Gain/Loss |
|
|
1,356,828 |
|
|
|
- |
|
| Net Operating Losses |
|
|
9,666,591 |
|
|
|
6,262,113 |
|
| Business Credit Carryforward |
|
|
1,426,116 |
|
|
|
1,426,117 |
|
| Capitalized R & D |
|
|
449,626 |
|
|
|
- |
|
| Other assets |
|
|
109,616 |
|
|
|
13,634 |
|
| Total deferred tax assets |
|
|
13,880,218 |
|
|
|
8,017,576 |
|
| |
|
|
|
|
|
|
|
|
| Deferred tax liabilities: |
|
|
|
|
|
|
|
|
| Unrealized F/X |
|
|
(54,729 |
) |
|
|
- |
|
| Other Liabilities |
|
|
(66,614 |
) |
|
|
- |
|
| Total deferred tax liabilities |
|
|
(121,343 |
) |
|
|
- |
|
| |
|
|
|
|
|
|
|
|
| Valuation allowance |
|
|
(13,758,875 |
) |
|
|
(8,017,576 |
) |
| Net deferred tax assets |
|
$ |
- |
|
|
$ |
- |
|
The Company has federal net operating loss carryforwards of approximately
$46.3 million at December 31, 2022, of which about $646,000 begin to expire in 2035 and the remainder have no expiration. The Company
has recorded a full valuation allowance against its net deferred tax assets due to recurring net losses.
|